Company Filing History:
1 out of 33 
1 out of 1,743 
1 out of 318 
Years Active: 2022
Title: Benoît Salomon: Innovator in Hematologic Malignancy Treatment
Introduction
Benoît Salomon is a notable inventor based in Saint-Maur, France. He has made significant contributions to the field of hematology, particularly in the prevention and treatment of hematologic malignancies. His innovative work has the potential to impact many lives through advancements in medical treatments.
Latest Patents
Benoît Salomon holds a patent for the prevention or treatment of hematologic malignancy relapse using a TNFR2 antagonist. This patent focuses on the in vivo prevention or treatment of relapse after allogeneic hematopoietic stem cell transplantation (AHCT) or treatment with lymphocytes. The invention aims to enhance the graft-versus-leukemia activity of hematopoietic stem cell transplantation or lymphocyte treatments.
Career Highlights
Throughout his career, Benoît has worked with esteemed institutions such as Université Paris Est Créteil Val De Marne and the Institut National de la Santé et de la Recherche Médicale. His dedication to research and innovation has established him as a respected figure in his field.
Collaborations
Benoît has collaborated with notable professionals, including Sébastien Maury and José Cohen. These partnerships have contributed to the advancement of his research and the development of his patent.
Conclusion
Benoît Salomon's work in the field of hematologic malignancies showcases his commitment to improving patient outcomes through innovative treatments. His contributions are a testament to the importance of research and collaboration in the medical field.